Heidi Wahamaa

Heidi Wahamaa

Auto-generated profile, based on publicly available information

Heidi Wahamaa

Rheumatology Unit, Department of Medicine, Sweden, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
CCCarmelo Carmona-Rivera
Carmelo Carmona-Rivera
PCPhilip M. Carlucci
Philip M. Carlucci
EMErica Moore
Erica Moore
NLNithya Lingampalli
Nithya Lingampalli
HUHannes Uchtenhagen
Hannes Uchtenhagen
MKMariana J. Kaplan
Mariana J. Kaplan
Neutrophil extracellular traps containing citrullinated peptides promote inflammation in synovial fibroblasts.

9 April 2018 in ACS Chemical Biology
Verified
Journal Article
Closed access
SGSunithi Gunasekera
Sunithi Gunasekera
CFCátia Fernandes-Cerqueira
Cátia Fernandes-Cerqueira
SWStefan Wennmalm
Stefan Wennmalm
HWHeidi Wähämaa
Heidi Wähämaa
YSYngve Sommarin
Yngve Sommarin
UGUlf Göransson
Ulf Göransson

1 March 2019 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
CGC Grasso
C Grasso
JHJs Hähnlein
Js Hähnlein
RNReza Nadafi
Reza Nadafi
TJTa De Jong
Ta De Jong
TRTh Ramwadhdoebe
Th Ramwadhdoebe
LBLgm Van Baarsen
Lgm Van Baarsen
Career situation of first and presenting author Student for a master or a PhD. Introduction In rheumatoid arthritis (RA) the cause for loss of tolerance and anti–citrullinated protein antibody (ACPA) production remains unidentified. Mouse studies showed that peripheral tolerance can be maintained through presentation of peripheral tissue antigens (PTAs) by lymph node stromal cells (LNSCs). We hypothesize that deregulation of peripheral tolerance mechanisms mediated by LNSCs might underlie pathogenesis of RA. Here we investigated the expression of PTAs, citrullinated proteins and immunomodulatory molecules by human LNSCs during health and autoimmunity. Methods LN tissue sections and LNSCs were prepared from freshly collected lymph node needle biopsies obtained from 24 patients with RA, 23 individuals positive for autoantibodies but without clinical apparent disease (RA-risk group) and 14 seronegative healthy controls. Expression of PADI enzymes, citrullinated proteins, DEAF1, AIRE and PTAs was investigated at mRNA and protein level. Expression of immunomodulatory molecules in LNSCs was assessed after stimulation with IFNγ (n=15). Results Citrinullated proteins, targeted by ACPA, were found in human LN tissue as well as in cultured LNSCs. In addition, we observed the expression of transcription factors AIRE and DEAF1 as well as disease-related PTAs in LNSCs with some PTAs showing a distinct expression pattern in autoimmune LNSCs compared to healthy controls. TGF-β was constitutively expressed by LNSCs while CD86 or IL-10 were not detected. Upon IFNγ stimulation LNSCs upregulated MHC class II, co-stimulatory molecules CD40 and CD80 as well as T cell negative regulators CD274, NOS2 and IDO. Overall, no clear differences between donor groups were observed for these markers with exception of a slightly lower induction of CD40 and NOS2 in RA LNSCs. Conclusions We present for the first time that human LNSCs express several PTAs and the transcription factors AIRE and DEAF1, driving PTA expression. Additionally, human LNSCs express molecules involved in citrullination, antigen presentation and immunomodulation. Moreover, antigens targeted by ACPAs are present in LN tissue and LNSCs. These data suggest that LNSCs have the machinery to regulate peripheral tolerance. Disclosure of Interest None declared.